AI-Powered Breast Surgical Planning Technology

This listing presents a pilot-stage company offering an innovative precision surgical planning technology focused on breast surgery. The technology aims to disrupt the aesthetic breast surgery market by eliminating scarring and reducing the risks associated with breast implants. It features a digital precision software solution, proprietary algorithmic planning on-cloud, and a patented myo-integration process, with a future pathway to an AI-assisted solution. The business operates on a scalable SaaS model and addresses a significant market need, with projections indicating a $2.0 billion SAM in the US. The company has successfully completed over 800 surgeries across 20 countries, demonstrating patient efficacy and positive outcomes. The technology focuses on using the patient's own tissue for breast reconstruction and enhancement, offering a safe alternative. The business participates in multi-billion dollar market segments with substantial growth potential.